Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2198977rdf:typepubmed:Citationlld:pubmed
pubmed-article:2198977lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:2198977lifeskim:mentionsumls-concept:C0025815lld:lifeskim
pubmed-article:2198977lifeskim:mentionsumls-concept:C0282440lld:lifeskim
pubmed-article:2198977lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2198977lifeskim:mentionsumls-concept:C1096777lld:lifeskim
pubmed-article:2198977lifeskim:mentionsumls-concept:C0442117lld:lifeskim
pubmed-article:2198977pubmed:issue4lld:pubmed
pubmed-article:2198977pubmed:dateCreated1990-9-13lld:pubmed
pubmed-article:2198977pubmed:abstractTextFifty-nine patients commencing intramuscular sodium aurothiomalate therapy were randomized to receive three doses of 120 mg intramuscular depot methylprednisolone acetate or matching placebo at weeks 0, 4, and 8 in addition to chrysotherapy. The group receiving methylprednisolone had more rapid disease improvement. This advantage persisted for up to 12 weeks, although by 24 weeks both groups exhibited similar benefits due to continued improvement in the group treated with gold alone. Withdrawals secondary to gold-induced side-effects occurred later in the steroid group (median time to withdrawal: 15 weeks steroid; 4.5 weeks placebo, P less than 0.05), and there were fewer withdrawals due to a lack of effect in the steroid group (one steroid versus three placebo, P NS). We conclude that glucocorticoids given as intermittent, intramuscular depot injections have a significant short term benefit which can be maintained by concomitant administration of intramuscular gold.lld:pubmed
pubmed-article:2198977pubmed:languageenglld:pubmed
pubmed-article:2198977pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2198977pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2198977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2198977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2198977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2198977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2198977pubmed:statusMEDLINElld:pubmed
pubmed-article:2198977pubmed:monthAuglld:pubmed
pubmed-article:2198977pubmed:issn0263-7103lld:pubmed
pubmed-article:2198977pubmed:authorpubmed-author:GibsonTTlld:pubmed
pubmed-article:2198977pubmed:authorpubmed-author:PanayiG SGSlld:pubmed
pubmed-article:2198977pubmed:authorpubmed-author:KirkhamB WBWlld:pubmed
pubmed-article:2198977pubmed:authorpubmed-author:ChikanzaI CIClld:pubmed
pubmed-article:2198977pubmed:authorpubmed-author:CorkillM MMMlld:pubmed
pubmed-article:2198977pubmed:issnTypePrintlld:pubmed
pubmed-article:2198977pubmed:volume29lld:pubmed
pubmed-article:2198977pubmed:ownerNLMlld:pubmed
pubmed-article:2198977pubmed:authorsCompleteYlld:pubmed
pubmed-article:2198977pubmed:pagination274-9lld:pubmed
pubmed-article:2198977pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:meshHeadingpubmed-meshheading:2198977-...lld:pubmed
pubmed-article:2198977pubmed:year1990lld:pubmed
pubmed-article:2198977pubmed:articleTitleIntramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial.lld:pubmed
pubmed-article:2198977pubmed:affiliationRheumatology Unit, United Medical School, Guy's Hospital, London.lld:pubmed
pubmed-article:2198977pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2198977pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2198977pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2198977pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2198977lld:pubmed